Home>Events>JLABS and MilliporeSigma Discussion Panel Event
Navigating technical and regulatory
challenges with confidence
ADC | MilliporeSigma

JLABS and MilliporeSigma Discussion Panel Event

Tuesday, May 15 and Thursday, May 17

Join us and your peers for this event to discuss challenges when transitioning from pre-clinical to clinical.

Tuesday, May 15, 2018   JLABS @ San Diego
3210 Merryfield Row
San Diego, CA 92121
3:30pm - 6:30pm
Sorry, this event is full. Registration is no longer possible.

Snacks and refreshments will be served.

Thursday, May 17, 2018 JLABS @ SSF
329 Oyster Point Blvd, 3rd Floor
SSF, CA 94080
3:30pm - 6:30pm
Sorry, this event is full. Registration is no longer possible.

Snacks and refreshments will be served.

Mercrobe MilliporeSigma

Abstract

It is critical to anticipate and overcome challenges rapidly when transitioning from pre-clinical POC studies into clinical studies in drug development. The earlier you consider the risks and long-term effects of raw materials, technologies and process performance, the higher your chances of succeeding in development.

Key considerations regarding raw materials, supply chain robustness, technology scalability and validation requirements are often underestimated. However, if one of these areas is not properly managed, it could lead to serious project delays and can potentially compromise the development and commercialization of pioneering drug therapies.

This presentation and subsequent panel discussion will:

  • Bring to light the challenges encountered when going from animal testing to first-in-human studies
  • Consider factors which can mitigate potential pitfalls
  • Share ideas on how to facilitate a seamless transition
Agenda
  • Welcome
  • Start with the end in mind
  • Panel discussion and Q&A
  • Networking reception & technical posters
Attendance to this panel event is limited and available to pharma/biopharma manufacturers and academics only. The offer does not extend to any company that provides products or services to the pharma/biopharma industry. MilliporeSigma reserves the right to revoke or refuse participation at any times. Coffee breaks are provided courtesy of MilliporeSigma. Travel costs, hotel accommodations and any other costs incurred are at the expense of the attendees.